Lidia Lugo
FDA investigator
Appears on 1 document from 2017, mostly at sites in India. Most often cites sampling and testing of in-process materials and drug products (21 CFR 211.110).
- 1
- Documents on file
- 1.0
- Observations per 483
- 2017
- First seen
- 2017
- Most recent
What they cite most
From 1 observations- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
Activity by year
2017: 1
Where
India 1
Often inspects with
Is Lidia Lugo coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2017-03-31 | 483 Glcnmark Pharmaceuticals LimitedMar 31, 2017 · Colvale-Bardez, India | Colvale-Bardez, India | 1 |
About this profile
What does Lidia Lugo inspect?
Lidia Lugo appears on 1 document on file covering 1 site, mostly in India.
What do they cite most often?
21 CFR 211.110 (sampling and testing of in-process materials and drug products).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Lidia Lugo is dated Mar 31, 2017.